NASDAQ:EPRX | Free Cash Flow | EUPRAXIA PHARMACEUTICALS INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$28.55M
2024-12-31-$29.99M
2023-12-31-$20.75M
2022-12-31-$14.4M